Latest Articles
-
Patient Perspectives Will Inform PQA’s Prioritization of Health Plan Measure Concepts
PQA is launching a Health Plan Measure Concept Advisory Group (MCAG) to review and provide input on measure concepts for development in 2026 and beyond. The group will provide guidance to prioritize health plan measure concepts, evaluating key criteria such as: The MCAG will be composed of 20-25 subject matter experts from PQA member organizations. […] -
Five for Friday March 28: Celebrating Success in Advancing Medication Use Quality
Welcome to the 100th edition of Five For Friday! This series began four years ago, shortly after I joined PQA. The vision was to highlight our members’ amazing work to improve medication use quality. Since then, we have shared 300 news stories featuring nearly 200 organizations. Many of those stories profile the cross-sector collaborations that […] -
Five for Friday March 14: Celebrating Success in Advancing Medication Use Quality
In 2023, PQA launched a multiphase national medication therapy management (MTM) initiative to address stakeholder needs and advance MTM quality measurement. PQA has identified six objectives that can advance MTM quality and measurement, and the MTM Advisory Group is serving as a forum providing expert feedback on how to approach these. As a first step, the PQA […] -
Prioritizing Access to Care and Health Equity at PQA
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a person’s ability to access and use medications. As we work to address health equity and social determinants of health that affect medication use quality and patient outcomes, we believe that a diverse, equitable and inclusive workforce will strengthen […] -
Five for Friday February 28: Celebrating Success in Advancing Medication Use Quality
PQA is now accepting self-nominations for the Diversity in Quality Scholarship. The program provides scholarships for health care professional students to attend the 2025 PQA Annual Meeting, May 19-21, in Tampa, Fla., and participate in the pre-meeting Medication Use Quality Live workshop on May 19. This scholarship opportunity is part of the PQA Diverse Quality Leaders Program and our commitment to build a […] -
Evaluating the Medication Therapy Management Program Using the Andersen Behavioral Model
The Medicare Part D medication therapy management (MTM) program aims to optimize therapeutic outcomes and reduce the risk of adverse events and associated costs by identifying and addressing medication therapy problems. There are specific eligibility criteria for Medicare beneficiaries to take advantage of these services. However, a significant portion of those eligible do not choose […] -
Five for Friday February 14: Celebrating Success in Advancing Medication Use Quality
Join us as we head to the Sunshine State for the 2025 PQA Annual Meeting, May 19-21! Meeting registration and hotel reservations are now open—don’t miss your chance to participate! Make your plans to join us and other quality professionals in Tampa at the primer event for quality medication use. Enhance the impact of your attendance by becoming a sponsor […] -
Patients’ Experience with Comprehensive Medication Reviews
PQA and research partners at the University of Arizona, the University of Health Sciences and Pharmacy in St. Louis, and Merck & Co. recently conducted patient interviews to explore patients’ perceptions of their experience with comprehensive medication reviews (CMR). This work was published in the December 2024 issue of the Journal of Managed Care & […] -
Five for Friday January 31: Celebrating Success in Advancing Medication Use Quality
PQA has published a new report that summarizes the conversations from PQA Convenes: Quality Medication Use in Rare Disease, held on November 7, which brought together health care quality experts, rare disease leaders and individuals with lived experience to discuss what constitutes high-quality rare disease medication use. This report compiles perspectives shared over four discussion panels. Several […] -
Use of PQA’s SDOH Resource Guide to Address Barriers in Patients’ Medication Access Journey
Barriers to medication access are a public health issue that affect adherence and patient outcomes. PQA emphasizes the pharmacist’s role in medication access and developed the Medication Access Patient Journey (MAPJ) conceptual framework that defines a patient’s medication access journey and characterizes barriers frequently encountered while seeking medication access. This framework highlights seven steps, or […]
PQA In the News
-
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
-
Part D adherence measures save billions, says Ben Shirley of PQA | Part 1
-
PQA Resource Guide Details Strategic Approaches to SDOH Intervention Success
-
2026 Health Care Outlook: Micah Cost, PQA
-
PQA Endorses One Quality Measures and Retires Three Quality Measures
Request a PQA Expert
For members of the media or who wish to speak with an expert source on quality, please contact:
Download Media Materials
For PQA logos, images and other communications collateral, please contact:
Leading the Conversation About Medication Quality
“Quality medication use is essential to value-based, person-centered care. Through connection, collaboration, and consensus, PQA drives improvements to promote the best medication-related care and outcomes for patients.”
Micah Cost, PharmD, MS, CAE, Chief Executive Officer
Strategic Media Partnerships
PQA partners with a variety of media to provide news, insights and opinions.
Stay Informed
Get the latest PQA news and events delivered to your inbox.